Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomePreferred Shares IssuedShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Net Cash Flow: 2014-2025

Historic Net Cash Flow for vTv Therapeutics (VTVT) over the last 11 years, with Sep 2025 value amounting to $72.6 million.

  • vTv Therapeutics' Net Cash Flow rose 1935.20% to $72.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.9 million, marking a year-over-year increase of 70.80%. This contributed to the annual value of $27.3 million for FY2024, which is 1118.66% up from last year.
  • Latest data reveals that vTv Therapeutics reported Net Cash Flow of $72.6 million as of Q3 2025, which was up 1,512.93% from -$5.1 million recorded in Q2 2025.
  • In the past 5 years, vTv Therapeutics' Net Cash Flow registered a high of $72.6 million during Q3 2025, and its lowest value of -$6.7 million during Q2 2024.
  • In the last 3 years, vTv Therapeutics' Net Cash Flow had a median value of -$4.4 million in 2023 and averaged $7.9 million.
  • Per our database at Business Quant, vTv Therapeutics' Net Cash Flow slumped by 499.42% in 2024 and then surged by 1,935.20% in 2025.
  • Over the past 5 years, vTv Therapeutics' Net Cash Flow (Quarterly) stood at -$6.2 million in 2021, then surged by 47.76% to -$3.2 million in 2022, then soared by 137.60% to $1.2 million in 2023, then slumped by 499.42% to -$4.8 million in 2024, then skyrocketed by 1,935.20% to $72.6 million in 2025.
  • Its last three reported values are $72.6 million in Q3 2025, -$5.1 million for Q2 2025, and -$5.7 million during Q1 2025.